Habil Khorakiwala, Founder, Chairman and Group CEO, Wockhardt says US FDA granting a QIDP status to WCK 5222 drug makes it the only company globally to receive this status for its fourth drug.
first published: Dec 8, 2015 04:48 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Slips Over 150 Points From Day's High But Gains For 6th Day| IT Stocks Surge|Closing Bell Live
Jigar Mistry flags potential risk to markets and what investors need to be cautious about
Will Nifty Clinch All-Time High As GIFT Nifty Signals Big Gap Up? HUL Q2 Today| Opening Bell Live
EU Ramps Up Ukraine Aid, Tomahawk Missiles as Trump-Putin Ceasefire Talks Risk Donbas Territory Loss
